E-Qure Corp.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EQUR research report →
Companywww.e-qure.com
E-Qure Corp. , a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure.
- CEO
- Ohad Goren
- IPO
- 1994
- Employees
- 1
- HQ
- New York City, NY, US
Price Chart
Valuation
- Market Cap
- $6.91K
- P/E
- -0.01
- P/S
- 0.00
- P/B
- -0.02
- EV/EBITDA
- -0.15
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 175.41%
- ROIC
- 262.00%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-577,051 · -30.02%
- EPS
- $-0.02 · -30.47%
- Op Income
- $-647,661
- FCF YoY
- 21.42%
Performance & Tape
- 52W High
- $0.05
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.01
- Beta
- 1.15
- Avg Volume
- 286
Get TickerSpark's AI analysis on EQUR
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 22, 14 | WEISSBERG RON | sell | 62,380 |
Our EQUR Coverage
We haven't published any research on EQUR yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate EQUR Report →